@article{magnusson_prevalence_2023,
	title = {Prevalence of long {COVID} complaints in persons with and without {COVID}-19},
	volume = {13},
	copyright = {2023 The Author(s)},
	issn = {2045-2322},
	url = {https://www.nature.com/articles/s41598-023-32636-y},
	doi = {10.1038/s41598-023-32636-y},
	abstract = {We studied the prevalence and patterns of typical long COVID complaints in {\textasciitilde} 2.3 million individuals aged 18–70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study in Norway. Our main outcome measures were the period prevalence of single-occurring or different combinations of complaints based on medical records: (1) Pulmonary (dyspnea and/or cough), (2) Neurological (concentration problems, memory loss), and/or (3) General complaints (fatigue). In persons testing positive (n = 75 979), 64 (95\% confidence interval: 54 to 73) and 122 (111 to 113) more persons per 10 000 persons had pulmonary complaints 5–6 months after the test compared to 10 000 persons testing negative (n = 1 167 582) or untested (n = 1 084 578), respectively. The corresponding difference in prevalence of general complaints (fatigue) was 181 (168 to 195) and 224 (211 to 238) per 10 000, and of neurological complaints 5 (2 to 8) and 9 (6–13) per 10 000. Overlap between complaints was rare. Long COVID complaints were only slightly more prevalent in persons with than without confirmed COVID-19. Still, long COVID may pose a substantial burden to healthcare systems in the future given the lasting high incidence of symptomatic COVID-19 in both vaccinated and unvaccinated individuals.},
	language = {en},
	number = {1},
	urldate = {2023-04-18},
	journal = {Scientific Reports},
	author = {Magnusson, Karin and Turkiewicz, Aleksandra and Flottorp, Signe Agnes and Englund, Martin},
	month = apr,
	year = {2023},
	note = {Number: 1
Publisher: Nature Publishing Group},
	keywords = {Epidemiology, Fatigue, Immunology, Infectious diseases, Public health, Signs and symptoms, Viral infection},
	pages = {6074},
}

{"_id":"XZeB9TvqiwDXzsnFm","bibbaseid":"magnusson-turkiewicz-flottorp-englund-prevalenceoflongcovidcomplaintsinpersonswithandwithoutcovid19-2023","author_short":["Magnusson, K.","Turkiewicz, A.","Flottorp, S. A.","Englund, M."],"bibdata":{"bibtype":"article","type":"article","title":"Prevalence of long COVID complaints in persons with and without COVID-19","volume":"13","copyright":"2023 The Author(s)","issn":"2045-2322","url":"https://www.nature.com/articles/s41598-023-32636-y","doi":"10.1038/s41598-023-32636-y","abstract":"We studied the prevalence and patterns of typical long COVID complaints in ~ 2.3 million individuals aged 18–70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study in Norway. Our main outcome measures were the period prevalence of single-occurring or different combinations of complaints based on medical records: (1) Pulmonary (dyspnea and/or cough), (2) Neurological (concentration problems, memory loss), and/or (3) General complaints (fatigue). In persons testing positive (n = 75 979), 64 (95% confidence interval: 54 to 73) and 122 (111 to 113) more persons per 10 000 persons had pulmonary complaints 5–6 months after the test compared to 10 000 persons testing negative (n = 1 167 582) or untested (n = 1 084 578), respectively. The corresponding difference in prevalence of general complaints (fatigue) was 181 (168 to 195) and 224 (211 to 238) per 10 000, and of neurological complaints 5 (2 to 8) and 9 (6–13) per 10 000. Overlap between complaints was rare. Long COVID complaints were only slightly more prevalent in persons with than without confirmed COVID-19. Still, long COVID may pose a substantial burden to healthcare systems in the future given the lasting high incidence of symptomatic COVID-19 in both vaccinated and unvaccinated individuals.","language":"en","number":"1","urldate":"2023-04-18","journal":"Scientific Reports","author":[{"propositions":[],"lastnames":["Magnusson"],"firstnames":["Karin"],"suffixes":[]},{"propositions":[],"lastnames":["Turkiewicz"],"firstnames":["Aleksandra"],"suffixes":[]},{"propositions":[],"lastnames":["Flottorp"],"firstnames":["Signe","Agnes"],"suffixes":[]},{"propositions":[],"lastnames":["Englund"],"firstnames":["Martin"],"suffixes":[]}],"month":"April","year":"2023","note":"Number: 1 Publisher: Nature Publishing Group","keywords":"Epidemiology, Fatigue, Immunology, Infectious diseases, Public health, Signs and symptoms, Viral infection","pages":"6074","bibtex":"@article{magnusson_prevalence_2023,\n\ttitle = {Prevalence of long {COVID} complaints in persons with and without {COVID}-19},\n\tvolume = {13},\n\tcopyright = {2023 The Author(s)},\n\tissn = {2045-2322},\n\turl = {https://www.nature.com/articles/s41598-023-32636-y},\n\tdoi = {10.1038/s41598-023-32636-y},\n\tabstract = {We studied the prevalence and patterns of typical long COVID complaints in {\\textasciitilde} 2.3 million individuals aged 18–70 years with and without confirmed COVID-19 in a Nation-wide population-based prospective cohort study in Norway. Our main outcome measures were the period prevalence of single-occurring or different combinations of complaints based on medical records: (1) Pulmonary (dyspnea and/or cough), (2) Neurological (concentration problems, memory loss), and/or (3) General complaints (fatigue). In persons testing positive (n = 75 979), 64 (95\\% confidence interval: 54 to 73) and 122 (111 to 113) more persons per 10 000 persons had pulmonary complaints 5–6 months after the test compared to 10 000 persons testing negative (n = 1 167 582) or untested (n = 1 084 578), respectively. The corresponding difference in prevalence of general complaints (fatigue) was 181 (168 to 195) and 224 (211 to 238) per 10 000, and of neurological complaints 5 (2 to 8) and 9 (6–13) per 10 000. Overlap between complaints was rare. Long COVID complaints were only slightly more prevalent in persons with than without confirmed COVID-19. Still, long COVID may pose a substantial burden to healthcare systems in the future given the lasting high incidence of symptomatic COVID-19 in both vaccinated and unvaccinated individuals.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2023-04-18},\n\tjournal = {Scientific Reports},\n\tauthor = {Magnusson, Karin and Turkiewicz, Aleksandra and Flottorp, Signe Agnes and Englund, Martin},\n\tmonth = apr,\n\tyear = {2023},\n\tnote = {Number: 1\nPublisher: Nature Publishing Group},\n\tkeywords = {Epidemiology, Fatigue, Immunology, Infectious diseases, Public health, Signs and symptoms, Viral infection},\n\tpages = {6074},\n}\n","author_short":["Magnusson, K.","Turkiewicz, A.","Flottorp, S. A.","Englund, M."],"key":"magnusson_prevalence_2023","id":"magnusson_prevalence_2023","bibbaseid":"magnusson-turkiewicz-flottorp-englund-prevalenceoflongcovidcomplaintsinpersonswithandwithoutcovid19-2023","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41598-023-32636-y"},"keyword":["Epidemiology","Fatigue","Immunology","Infectious diseases","Public health","Signs and symptoms","Viral infection"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/groups/5155143/items?key=IVTAjWy1U5EkGJqE2Z2qQCfh&format=bibtex&limit=100","dataSources":["7PYyrRz6AvkoBBchz","5jEuhQhgRx3py8LmG"],"keywords":["epidemiology","fatigue","immunology","infectious diseases","public health","signs and symptoms","viral infection"],"search_terms":["prevalence","long","covid","complaints","persons","without","covid","magnusson","turkiewicz","flottorp","englund"],"title":"Prevalence of long COVID complaints in persons with and without COVID-19","year":2023}